Related Experiment Video
Updated: May 28, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
[Rotavirus vaccination in Europe in 2010]
1Hôpital Trousseau, 26, avenue du Docteur Arnold Netter, 75012 Paris. emmanuel.grimprel@trs.aphp.fr
Abstract:
The important burden of rotavirus infections in infants largely justifies vaccine prevention. Two attenuated oral vaccines were licensed in Europe in 2006 and have proven effective against severe rotavirus gastroenteritis in infants, yet few countries have implemented vaccination. This hesitation may be related to a very low risk of intussusception in vaccinees, but is mainly due to national differences in cost-effectiveness.
Related Concept Videos
Vaccinations
Poliomyelitis
Respiratory Syncytial Virus Disease
Bacterial Gastroenteritis
Vaccines
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

